Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database

被引:0
|
作者
Xiongwen Yang
Bo Yang
Dan Li
Wei Pan
Qin Tong
Lili Wang
Danjun Chen
Chengxiao Fu
机构
[1] Hengyang Medical School,Department of Pharmacy, The First Affiliated Hospital
[2] University of South China,Institute of Pharmacy and Pharmacology, College of Basic Medical Science, Hengyang Medical School
[3] University of South China,Clinical Pharmacology Research Center, The First Affiliated Hospital
[4] Hengyang Medical School,Department of Oncology, The First Affiliated Hospital
[5] University of South China,undefined
[6] Hengyang Medical School,undefined
[7] University of South China,undefined
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:199 / 207
页数:8
相关论文
共 50 条
  • [1] Thromboembolic Events Associated with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Pharmacovigilance Analysis of the US FDA Adverse Event Reporting System (FAERS) Database
    Yang, Xiongwen
    Yang, Bo
    Li, Dan
    Pan, Wei
    Tong, Qin
    Wang, Lili
    Chen, Danjun
    Fu, Chengxiao
    CLINICAL DRUG INVESTIGATION, 2024, 44 (03) : 199 - 207
  • [2] Liver injury related to vascular endothelial growth factor tyrosine kinase inhibitors: a pharmacovigilance analysis of the USA FDA adverse event reporting system (FAERS) database
    Wang, Xiang
    Chen, Rujie
    Liu, Jialin
    Wang, E.
    Luo, Hui
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [3] Pharmacovigilance analysis of orlistat adverse events based on the FDA adverse event reporting system (FAERS) database
    Zhu, Jinfeng
    Hu, Mianda
    Liang, Yingshi
    Zhong, Mingjun
    Chen, Zilin
    Wang, Zhenjie
    Yang, Yujia
    Luo, Ziyi
    Zeng, Wenqi
    Li, Jiahui
    Du, Yikuan
    Liu, Yi
    Yang, Chun
    HELIYON, 2024, 10 (14)
  • [4] Adverse events associated with acute pancreatitis caused by immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA adverse event reporting system (FAERS) database
    Tong, Lihua
    Yuan, Yanling
    He, Wanming
    Yang, Wen
    Pan, Xingxi
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [5] Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
    Huang, Jing
    Meng, Long
    Yang, Bing
    Sun, Shusen
    Luo, Zhigang
    Chen, Hong
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [6] Safety Profile of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors: A Disproportionality Analysis of FDA Adverse Event Reporting System
    Jing Huang
    Long Meng
    Bing Yang
    Shusen Sun
    Zhigang Luo
    Hong Chen
    Scientific Reports, 10
  • [7] Pharmacovigilance Analysis Of FDA Adverse Event Reporting System (FAERS) Events For Inclisiran
    Rajak, Kripa
    Halder, Anupam
    Gautam, Seema Sharma
    Khanal, Resha
    Atrash, Anas
    Goswami, Rohan
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2023, 43
  • [8] Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Zhou, Chaozheng
    Peng, Shengkun
    Lin, Anqi
    Jiang, Aimin
    Peng, Yuanxi
    Gu, Tianqi
    Liu, Zaoqu
    Cheng, Quan
    Zhang, Jian
    Luo, Peng
    ECLINICALMEDICINE, 2023, 59
  • [9] Safety profiles of IDH inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
    Sun, Ximu
    Zhou, Han
    Li, Yanming
    Luo, Yanhui
    Guo, Qixiang
    Sun, Yixin
    Jia, Chenguang
    Wang, Bin
    Qin, Maoquan
    Guo, Peng
    FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2025, 11 (01)
  • [10] Pericardial Toxicities Associated With Immune Checkpoint Inhibitors: A Pharmacovigilance Analysis of the FDA Adverse Event Reporting System (FAERS) Database
    Ma, Zhuo
    Pei, Jie
    Sun, Ximu
    Liu, Lihong
    Lu, Wenchao
    Guo, Qixiang
    Lyu, Jiayou
    Liu, Yuwei
    Zhang, Yuhui
    Zhao, Zhixia
    FRONTIERS IN PHARMACOLOGY, 2021, 12